Motwani, K. K., Hashash, J. G., Farraye, F. A., Kappelman, M. D., Weaver, K. N., Zhang, X., . . . Cross, R. K. (2023). Impact of Holding Immunosuppressive Therapy in Patients with Inflammatory Bowel Disease Around mRNA COVID-19 Vaccine Administration on Humoral Immune Response and Development of COVID-19 Infection. Journal of Crohn's & Colitis, 17(10), 1681. https://doi.org/10.1093/ecco-jcc/jjad085
Chicago Style (17th ed.) CitationMotwani, Kiran K., Jana G. Hashash, Francis A. Farraye, Michael D. Kappelman, Kimberly N. Weaver, Xian Zhang, Millie D. Long, and Raymond K. Cross. "Impact of Holding Immunosuppressive Therapy in Patients with Inflammatory Bowel Disease Around MRNA COVID-19 Vaccine Administration on Humoral Immune Response and Development of COVID-19 Infection." Journal of Crohn's & Colitis 17, no. 10 (2023): 1681. https://doi.org/10.1093/ecco-jcc/jjad085.
MLA (9th ed.) CitationMotwani, Kiran K., et al. "Impact of Holding Immunosuppressive Therapy in Patients with Inflammatory Bowel Disease Around MRNA COVID-19 Vaccine Administration on Humoral Immune Response and Development of COVID-19 Infection." Journal of Crohn's & Colitis, vol. 17, no. 10, 2023, p. 1681, https://doi.org/10.1093/ecco-jcc/jjad085.